Welcome to the e-CCO Library Archive!

search
                             
search by: 
Filter:
P226. Non-invasive monitoring of inflammatory bowel disease: Need for better tools?
P226. Prevention of infusion reactions to infliximab in pediatric patients
P226

Consistently high C reactive protein is associated with subsequent development of perianal fistulae in patients with Crohn's disease.

Authors:

G. Radford-Smith*1, E. Ferguson2, K. Hanigan3, L. Simms3, J. Irwin1

1Royal Brisbane and Women's Hospital, Gastroenterology, Brisbane, Australia, 2Royal Brisbane & Women's Hospital, Department of Gastroenterology, Brisbane, Australia, 3QIMR Berghofer Medical Research Institute, Complex Diseases, Brisbane, Australia

P227.

Evaluation of a method to detect cytomegalovirus-DNA in intestinal fluid samples of patients with ulcerative colitis

Authors:

A. Iraha1, T. Kinjo1, K. Kishimoto1, A. Hokama1, F. Kinjo1, A. Uehara2, J. Fujita2, 1University of the Ryukyus, Department of Endoscopy, Nishihara-cho, Okinawa, Japan, 2University of the Ryukyus, Internal Medicine (I), Nishihara-cho, Okinawa, Japan

P227. Efficacy of infliximab in paediatric Crohn's disease patients
P227. Evaluation of safety and effectiveness of adalimumab therapy in symptomatic ileal Crohn's disease strictures
P227. Impact of small intestine contrast ultrasonography in the management of Crohn's disease patients
Authors:

E. Calabrese1, F. Zorzi1, E. Stasi1, E. Lolli1, G. Condino1, C. Petruzziello1, L. Biancone1, F. Pallone1, 1University of Rome Tor Vergata, GI Unit, Medicine, Rome, Italy

P227

Lower serum albumin level on admission is a predictive factor of colectomy in patients with moderate to severe ulcerative colitis

Authors:

M. Tanaka*, Y. Hotta, K. Uchiyama, T. Takagi, Y. Naito

Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Department of Molecular Gastroenterology and Hepatology, 465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan

P228.

Evaluation of the correlation between serum levels of hepcidin and disease activity in inflammatory bowel diseases

Authors:

Z.B. Paköz, C. Çekiç, E.S. Yüksel, S. Vatansever, M. Arabul, B. Unsal, Katip Çelebi University, Atatürk Training and Research Hospital, Gastroenterology, Izmir, Turkey

P228. Awareness of adverse effects of azathioprine among patients with inflammatory bowel disease
P228. IgG4-positive plasma cells in the colon of patients with ulcerative colitis are markers of endoscopic and histological disease activity
Authors:

K. Orlicka1, E.L. Culver2, A.C. Bateman3, R. Sadler4, R.W. Chapman2, S. Keshav2, E. Barnes2, S.P. Travis2, 1John Radcliffe Hospital, Translational Gastroenterology Unit, Oxford, United Kingdom, 2John Radcliffe Hospital, Translational Gastroenterology Unit and Nuffield Department of Medicine, Oxford, United Kingdom, 3Southampton General Hospital, Histopathology Department, Southampton, United Kingdom, 4Churchill Hospital, Clinical Immunology Department, Oxford, United Kingdom

P228. Thiopurine methyltransferase genotype and thiopurine S‑methyltransferase activity in Greek children with inflammatory bowel disease
P228

Vaginal delivery is not associated with fecal incontinence in IBD women

Authors:

S. Kanis*, C. Van der Woude

Erasmus Medical Center, Gastroenterology and Hepatology, Rotterdam, Netherlands

P229.

Environmental and clinical risk factors for severe Crohn's disease

Authors:

N. Azzopardi1, P. Ellul1, S. Chetcuti1, G. Laferla2, 1Mater Dei Hospital, Gastroenterology, Tal Qroqq, Malta, 2University of Malta, Medicine & Surgery, Tal Qroqq, Malta

P229. Cell therapy and quality of life of patients with inflammatory bowel disease
P229. Is quality-of-life worse in perianal Crohn's disease patients?
Authors:

M. Barreiro-de Acosta1, M. Iglesias-Rey1, A. Lorenzo1, J.E. Dominguez-Munoz1, 1University Hospital, Gastroenterology, Santiago, Spain

P229. Kinetics of the Anti-HBs titers after vaccination against hepatitis B virus (HBV) in patients with inflammatory bowel disease (IBD)
P229

AlphaE (αE) integrin protein and gene expression are augmented in the ileum relative to the colon in Crohn's disease

Authors:

R. Ichikawa1, J. Eastham-Anderson1, A. Scherl1, G.W. Tew*1, J.G. Egen1, C.A. Lamb2, 3, J.C. Mansfield3, J.A. Kirby3, W.A. Faubion4, S. O'Byrne1, M.E. Keir1

1Genentech, ITGR Diagnostic Discovery, South San Francisco, United States, 2Newcastle University, Department of Gastroenterology, Newcastle Upon Tyne, United Kingdom, 3Newcastle University, Institute of Cellular Medicine, Newcastle Upon Tyne, United Kingdom, 4Mayo Clinic, Division of Gastroenterology & Hepatology, Rochester, United States

P230.

Endoscopy in IBD women is safe in each trimester of pregnancy

Authors:

A. de Lima1, Z. Zelinkova1,2, C. van der Ent1, C.J. van der Woude1, 1Erasmus Medical Center, Gastroenterology and Hepatology, Rotterdam, Netherlands, 2University Hospital, 5th Department of Internal Medicine, Gastroenterology Unit, Bratislava, Slovakia

P230. Adalimumab in active ulcerative colitis: A “real-life” observational study